Technology area: Biotechnology & Pharmaceuticals
36 pending office actions • 32 art units • 36 examiners • 0 of 36 (0%) have an AI response strategy ready • 49 patents granted in the last 365 days
Ajou University Industry-Academic Cooperation Foundation has 37 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 37 distinct examiners and 33 distinct art units, demonstrating broad distribution across both examination personnel and groups.
CAI, JIAJIA JANIE is the busiest examiner, with 1 pending matter. No examiner appears repeatedly in the listed data, so portfolio management must rely on centralized processes rather than an established examiner relationship.
Counsel should prioritize docket governance, consistent technical terminology, and systematic review of disclosure support across the applications. Each response will require tailoring to its assigned art unit and examiner, because the matters occupy separate prosecution contexts.
Based on the USPTO statutory response window for each pending office action. 9 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 9 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (3%) |
| §101 + other | 12 (33%) |
| §103 only | 7 (19%) |
| §112 only | 3 (8%) |
| Multi-statute (no §101) | 12 (33%) |
| No statute on record | 1 (3%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CAI, JIAJIA JANIE | 1 | 29.1% | +20.7% |
| ALLEN, KYLA GUAN-PING TI | 1 | 88.0% | +18.0% |
| LAOBAK, ANDREW KEELAN | 1 | 75.8% | +34.7% |
| LYJAK, LORI LYNN | 1 | 89.9% | +8.5% |
| MISTRY, ONEAL R | 1 | 87.5% | +11.3% |
| ABEYRATNE-PERERA, HASHANTHI KOMITIGE | 1 | 0.0% | +0.0% |
| SHUI, MING | 1 | 58.4% | +49.7% |
| TRAN, LOC | 1 | 83.9% | +24.1% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.4% | +24.3% |
| ZEROUAL, OMAR | 1 | 33.6% | +39.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18141086 | PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION AS OPHTHALMIC DROP TO PATIENT REQUIRING OPTIC NERVE PROTECTION | RICCI, CRAIG D | 190d overdue |
| 18032720 | OPTICAL SENSOR HAVING 2D-3D HETEROJUNCTION STRUCTURE AND MANUFACTURING METHOD THEREOF | REAMES, MATTHEW L | 42d overdue |
| 18274537 | BIO-SENSING DEVICE WITH OPTOELECTRONIC DEVICE | BRYANT, MICHAEL CASEY | 23d |
| 17797916 | COMPOSITION COMPRISING CHEMOKINE INHIBITOR, COLONY STIMULATING FACTOR INHIBITOR, AND CANCER IMMUNOTHERAPY AGENT FOR PREVENTION OR TREATMENT OF CANCER AND COMBINATION THERAPY | SULLIVAN, DENNIS JOHN | 26d |
| 18322850 | SERUM EXOSOMAL SF3B4 MARKER COMPOSITION FOR DIAGNOSING EARLY STAGE HEPATOCELLULAR CARCINOMA FOR NONINVASIVE IN VITRO DIAGNOSIS | BELLAH, JEFFREY LAWRENCE | 40d |
| 17907791 | BIOMARKER COMPOSITION FOR DIAGNOSING DIFFUSE TYPE GASTRIC CANCER, AND MEDICAL USE THEREOF | KENNEDY, SARAH JANE | 72d |
| 19057051 | CONDUCTIVE MATERIAL AND METHOD FOR MANUFACTURING THE SAME | CAI, JIAJIA JANIE | — |
| 19035188 | MULTI-DOMAIN OBJECT DETECTION METHOD AND APPARATUS | ALLEN, KYLA GUAN-PING TI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19057051 | CONDUCTIVE MATERIAL AND METHOD FOR MANUFACTURING THE SAME | CAI, JIAJIA JANIE | — |
| 19035188 | MULTI-DOMAIN OBJECT DETECTION METHOD AND APPARATUS | ALLEN, KYLA GUAN-PING TI | — |
| 18997923 | PLASMA ETCHING METHOD USING HEPTAFLUOROPROPYL METHYL ETHER AND HEPTAFLUOROISOPROPYL METHYL ETHER | LAOBAK, ANDREW KEELAN | — |
| 18999698 | SYSTEM AND METHOD OF MEDICAL IMAGE QUALITY FEEDBACK | MISTRY, ONEAL R | — |
| 18933486 | CHARACTER RECOGNITION AND DOCUMENT INTERPRETATION METHOD AND SYSTEM BASED ON LAYOUT RECOGNITION | SHUI, MING | — |
| 18929690 | SYSTEM AND METHOD FOR ANALYZING SENTENCE | TRAN, LOC | — |
| 18855162 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC STROKE, CONTAINING RAGE ANTAGONIST AND AGE SCAVENGER | WHITE, DAWANNA SHAR-DAY | — |
| 18901173 | METHOD FOR ACHIEVING CARBON NEUTRALITY BASED ON ESG IN INDUSTRIAL SITES AND APPARATUS THEREOF | ZEROUAL, OMAR | — |
| Art Unit | Apps |
|---|---|
| 1682 | 3 |
| 1683 | 2 |
| 1717 | 1 |
| 2661 | 1 |
| 1713 | 1 |
| 3612 | 1 |
| 2674 | 1 |
| 1632 | 1 |
| 2663 | 1 |
| 2164 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19057051 | CONDUCTIVE MATERIAL AND METHOD FOR MANUFACTURING THE SAME | CAI, JIAJIA JANIE | 1717 | §103 | Non-Final OA | — | Pending | Feb 19, 2025 |
| 19035188 | MULTI-DOMAIN OBJECT DETECTION METHOD AND APPARATUS | ALLEN, KYLA GUAN-PING TI | 2661 | §103§112 | Non-Final OA | — | Pending | Jan 23, 2025 |
| 18997923 | PLASMA ETCHING METHOD USING HEPTAFLUOROPROPYL METHYL ETHER AND HEPTAFLUOROISOPROPYL METHYL ETHER | LAOBAK, ANDREW KEELAN | 1713 | §103§112 | Non-Final OA | — | Pending | Jan 23, 2025 |
| 19001929 | VEHICLE FOR PERFORMING MINIMAL RISK MANEUVER AND METHOD OF OPERATING THE SAME | LYJAK, LORI LYNN | 3612 | — | Final Rejection | — | Pending | Dec 26, 2024 |
| 18999698 | SYSTEM AND METHOD OF MEDICAL IMAGE QUALITY FEEDBACK | MISTRY, ONEAL R | 2674 | §101§102§103 | Non-Final OA | — | Pending | Dec 23, 2024 |
| 18982276 | METHOD FOR PRODUCING INNER EAR ORGANOIDS USING RETINOIC ACID AND INNER EAR ORGANOIDS PRODUCED BY THE METHOD | ABEYRATNE-PERERA, HASHANTHI KOMITIGE | 1632 | §101§102§112 | Non-Final OA | — | Pending | Dec 16, 2024 |
| 18933486 | CHARACTER RECOGNITION AND DOCUMENT INTERPRETATION METHOD AND SYSTEM BASED ON LAYOUT RECOGNITION | SHUI, MING | 2663 | §101§102 | Final Rejection | — | Pending | Oct 31, 2024 |
| 18929690 | SYSTEM AND METHOD FOR ANALYZING SENTENCE | TRAN, LOC | 2164 | §102§103 | Final Rejection | — | Pending | Oct 29, 2024 |
| 18855162 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETIC STROKE, CONTAINING RAGE ANTAGONIST AND AGE SCAVENGER | WHITE, DAWANNA SHAR-DAY | 1627 | §102§103 | Non-Final OA | — | Pending | Oct 08, 2024 |
| 18901173 | METHOD FOR ACHIEVING CARBON NEUTRALITY BASED ON ESG IN INDUSTRIAL SITES AND APPARATUS THEREOF | ZEROUAL, OMAR | 3628 | §103§112 | Non-Final OA | — | Pending | Sep 30, 2024 |
| 18898326 | SURFACE MODIFICATION METHOD OF ZIRCONIA MATERIAL USING VACUUM PLASMA | BOWMAN, ANDREW J | 1741 | §103 | Non-Final OA | — | Pending | Sep 26, 2024 |
| 18746307 | METHOD AND APPARATUS FOR IMPROVING HYPERVISOR PERFORMANCE IN MEMORY DISAGGREGATION ENVIRONMENT | CASTANEDA, IVAN ALEXANDER | 2195 | §103§112 | Non-Final OA | — | Pending | Jun 18, 2024 |
| 18720453 | ANTI-STRESS COMPOSITION COMPRISING NATURAL EXTRACT MIXTURE, AND USE THEREOF | CHEN, CATHERYNE | 1655 | §101§102 | Non-Final OA | — | Pending | Jun 14, 2024 |
| 18700295 | COMPOSITION FOR DIAGNOSING PERIODONTAL DISEASE USING BACTERIAL POPULATION IN SALIVA, AND USE THEREOF | BUCHANAN, BAILEY CHEYENNE | 1682 | §101§103§112 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18700307 | COMPOSITION FOR DIAGNOSING PERIODONTAL DISEASES BY USING BACTERIAL CLUSTERS IN GINGIVAL CREVICULAR FLUID, AND USE THEREOF | DAUNER, JOSEPH G | 1682 | §101§102§103§112 | Non-Final OA | — | Pending | Apr 11, 2024 |
| 18699240 | DENTAL TITANIUM MATERIAL HAVING MODIFIED SURFACE, AND PREPARATION METHOD THEREFOR | LIANG, ANTHONY M | 1734 | §112 | Non-Final OA | — | Pending | Apr 05, 2024 |
| 18595389 | FEDERATED LEARNING METHOD AND DEVICE USING DEVICE CLUSTERING | ELL, MATTHEW | 2141 | §101§103 | Non-Final OA | — | Pending | Mar 04, 2024 |
| 18290613 | CELL-PENETRATING DEGRADING ANTIBODY THAT PENETRATES INTO CELLS TO DEGRADE AND REMOVE TARGET PROTEIN AND USE THEREOF | HOLTZMAN, KATHERINE ANN | 1646 | §112 | Non-Final OA | — | Pending | Jan 19, 2024 |
| 18561470 | PHARMACEUTICAL COMPOSITION COMPRISING HYALURONIC ACID COMPLEX FOR PREVENTION OR TREATMENT OF SKIN DISEASE | CREWS, JARET JAMES | 1691 | §103§112 | Final Rejection | — | Pending | Nov 16, 2023 |
| 18288502 | METHOD FOR PRODUCING COPPER COMPOSITE STRUCTURE, AND ENERGY STORAGE DEVICE AND SUBSTRATE STRUCTURE FOR RAMAN SCATTERING INCLUDING COPPER COMPOSITE STRUCTURE PRODUCED THEREBY | LOUIE, MANDY C | — | §102§103 | Non-Final OA | — | Pending | Oct 26, 2023 |
| 18476715 | ELECTRONIC DEVICE FOR PROVIDING REAL-TIME EMOTIONAL FEEDBACK TO USER'S WRITING, METHOD THEREOF AND CLASSIFICATION SEVER FOR ANALYZING REAL-TIME EMOTIONAL FEEDBACK | WEAVER, ADAM MICHAEL | 2658 | §103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18472987 | COMPOSITION FOR PREVENTING OR TREATING OF ISCHEMIC CEREBROVASCULAR DISEASE COMPRISING AN ARGINASE-1 INHIBITOR | MARCSISIN, ELLEN JEAN | 1677 | §101§102§112 | Non-Final OA | — | Pending | Sep 22, 2023 |
| 18281460 | TARGET ANALYTE DETECTION METHOD BASED ON PROXIMITY PROTEOLYSIS REACTION | HOWARD, ZACHARY C | 1674 | §101§112 | Non-Final OA | — | Pending | Sep 11, 2023 |
| 18244044 | METHOD AND APPARATUS FOR CHECKING OF MENTAL HEALTH USING CONTENTS | ANTOINE, LISA HOPE | 3715 | §101§103 | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18266581 | METHOD FOR CONFIGURING UAV NETWORK BY UTILIZING MULTIMODAL SENSOR INFORMATION | JAVAID, JAMAL | 2412 | §103 | Non-Final OA | 30d | Pending | Aug 03, 2023 |
| 18274537 | BIO-SENSING DEVICE WITH OPTOELECTRONIC DEVICE | BRYANT, MICHAEL CASEY | 2884 | §103§112 | Final Rejection | 23d | Pending | Jul 27, 2023 |
| 18344488 | PLASMA TREATMENT DEVICE | HALL, DEANNA K | 3783 | §103 | Non-Final OA | 33d | Pending | Jun 29, 2023 |
| 18265218 | PHOTO-CROSSLINKED HYALURONIC ACID BIO-INK FOR BIO-PRINTING, METHOD FOR PREPARING SAME, AND BIOLOGICAL STRUCTURE CAPABLE OF CONTROLLING PHYSICAL PROPERTIES USING SAME | KAUCHER, MARK S | 1764 | §103 | Non-Final OA | 14d | Pending | Jun 02, 2023 |
| 18322850 | SERUM EXOSOMAL SF3B4 MARKER COMPOSITION FOR DIAGNOSING EARLY STAGE HEPATOCELLULAR CARCINOMA FOR NONINVASIVE IN VITRO DIAGNOSIS | BELLAH, JEFFREY LAWRENCE | 1683 | §101§103 | Final Rejection | 40d | Pending | May 24, 2023 |
| 18141086 | PHARMACEUTICAL COMPOSITION FOR ADMINISTRATION AS OPHTHALMIC DROP TO PATIENT REQUIRING OPTIC NERVE PROTECTION | RICCI, CRAIG D | 1611 | §101§103§112 | Non-Final OA | 190d overdue | Pending | Apr 28, 2023 |
| 18032720 | OPTICAL SENSOR HAVING 2D-3D HETEROJUNCTION STRUCTURE AND MANUFACTURING METHOD THEREOF | REAMES, MATTHEW L | 2896 | §102§103§112 | Non-Final OA | 42d overdue | Pending | Apr 19, 2023 |
| 18025833 | ANTIBODY BINDING HUMAN IL-5R alpha AND USE THEREOF | ROONEY, NORA MAUREEN | 1641 | §112 | Final Rejection | — | Pending | Mar 10, 2023 |
| 17907791 | BIOMARKER COMPOSITION FOR DIAGNOSING DIFFUSE TYPE GASTRIC CANCER, AND MEDICAL USE THEREOF | KENNEDY, SARAH JANE | 1682 | §103§112 | Non-Final OA | 72d | Pending | Aug 29, 2022 |
| 17797916 | COMPOSITION COMPRISING CHEMOKINE INHIBITOR, COLONY STIMULATING FACTOR INHIBITOR, AND CANCER IMMUNOTHERAPY AGENT FOR PREVENTION OR TREATMENT OF CANCER AND COMBINATION THERAPY | SULLIVAN, DENNIS JOHN | 1642 | §103§112 | Non-Final OA | 26d | Pending | Aug 05, 2022 |
| 17568321 | METHOD AND APPARATUS FOR TRACING FAULT OF COLLABORATIVE ROBOT | OSTROW, ALAN LINDSAY | 3657 | §101 | Final Rejection | — | Pending | Jan 04, 2022 |
| 17282650 | TARGET NUCLEIC ACID DETECTION METHOD BASED ON PROXIMITY PROTEOLYSIS REACTION | POHNERT, STEVEN C | 1683 | §103 | Final Rejection | — | Pending | Apr 02, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAjou University Industry-Academic Cooperation Foundation has 36 pending office actions as of October 2026, spread across 32 art units and 36 examiners.
Jiajia Janie Cai has the most, with 1 of Ajou University Industry-Academic Cooperation Foundation's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
